This invention relates generally to novel triazolone and triazolethione derivatives as {HEAD ~ inhibitors} of matrix metalloproteinases , TNF α converting enzyme , aggrecanase or {TAIL ~ a combination} thereof, pharmaceutical compositions containing the same, and methods of using the same 
of
This invention relates generally to novel triazolone and triazolethione derivatives as { HEAD ~ inhibitors } of matrix metalloproteinases , TNF α converting enzyme , aggrecanase or { TAIL ~ a combination } thereof , pharmaceutical compositions containing the same , and methods of using the same
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD REL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH